These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20431800)

  • 41. Association of apolipoprotein-CIII (apoC-III), endothelium-dependent vasodilation and peripheral neuropathy in a multi-ethnic population with type 2 diabetes.
    Pek SLT; Sum CF; Yeoh LY; Lee SBM; Tang WE; Lim SC; Tavintharan S
    Metabolism; 2017 Jul; 72():75-82. PubMed ID: 28641786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prevalence of diabetic peripheral neuropathy and related factors.
    Tabatabaei-Malazy O; Mohajeri-Tehrani M; Madani S; Heshmat R; Larijani B
    Iran J Public Health; 2011; 40(3):55-62. PubMed ID: 23113086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: A Nested Case-Control Study.
    Aleidan FAS; Ahmad BA; Alotaibi FA; Aleesa DH; Alhefdhi NA; Badri M; Abdel Gader AG
    Int J Gen Med; 2020; 13():881-889. PubMed ID: 33116780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.
    Kim ES; Lee SW; Mo EY; Moon SD; Han JH
    Endocrine; 2015 Nov; 50(2):405-12. PubMed ID: 25846483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nerve growth factor and expression of its receptors in patients with diabetic neuropathy.
    Kim HC; Cho YJ; Ahn CW; Park KS; Kim JC; Nam JS; Im YS; Lee JE; Lee SC; Lee HK
    Diabet Med; 2009 Dec; 26(12):1228-34. PubMed ID: 20002474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association Between Tumor Necrosis Factor-α and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: a Meta-Analysis.
    Mu ZP; Wang YG; Li CQ; Lv WS; Wang B; Jing ZH; Song XJ; Lun Y; Qiu MY; Ma XL
    Mol Neurobiol; 2017 Mar; 54(2):983-996. PubMed ID: 26797519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and clinical characteristics of restless legs syndrome in diabetic peripheral neuropathy: comparison with chronic osteoarthritis.
    Cho YW; Na GY; Lim JG; Kim SH; Kim HS; Earley CJ; Allen RP
    Sleep Med; 2013 Dec; 14(12):1387-92. PubMed ID: 24210603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetic neuropathy differs between type 1 and type 2 diabetes: Insights from magnetic resonance neurography.
    Jende JME; Groener JB; Oikonomou D; Heiland S; Kopf S; Pham M; Nawroth P; Bendszus M; Kurz FT
    Ann Neurol; 2018 Mar; 83(3):588-598. PubMed ID: 29443416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and Risk Factors of Diabetic Peripheral Neuropathy in T2DM Patient Presenting to Community Hospital in Nepal.
    Shrestha HK; Katwal PC
    Kathmandu Univ Med J (KUMJ); 2017; 17(58):146-149. PubMed ID: 34547847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and prevalence of diabetic polyneuropathy: a cross-sectional study of Danish patients with type 2 diabetes.
    Gylfadottir SS; Itani M; Krøigård T; Kristensen AG; Christensen DH; Nicolaisen SK; Karlsson P; Callaghan BC; Bennett DL; Andersen H; Tankisi H; Nielsen JS; Andersen NT; Jensen TS; Thomsen RW; Sindrup SH; Finnerup NB
    Eur J Neurol; 2020 Dec; 27(12):2575-2585. PubMed ID: 32909392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognosis of Diabetic Peripheral Neuropathy via Decomposed Digital Volume Pulse from the Fingertip.
    Wei HC; Hu WR; Ta N; Xiao MX; Tang XJ; Wu HT
    Entropy (Basel); 2020 Jul; 22(7):. PubMed ID: 33286526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association of diabetic microvascular and macrovascular disease with cutaneous circulation in patients with type 2 diabetes mellitus.
    Eleftheriadou I; Tentolouris A; Grigoropoulou P; Tsilingiris D; Anastasiou I; Kokkinos A; Perrea D; Katsilambros N; Tentolouris N
    J Diabetes Complications; 2019 Feb; 33(2):165-170. PubMed ID: 30446479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low levels of ficolin-3 are associated with diabetic peripheral neuropathy.
    Zhang X; Hu Y; Shen J; Zeng H; Lu J; Li L; Bao Y; Liu F; Jia W
    Acta Diabetol; 2016 Apr; 53(2):295-302. PubMed ID: 26116288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study.
    Qiao X; Zheng H; Zhang S; Liu S; Xiong Q; Mao F; Zhang Z; Wen J; Ye H; Li Y; Lu B
    Diabetol Metab Syndr; 2017; 9():12. PubMed ID: 28228847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin D deficiency increases the risk of peripheral neuropathy in Chinese patients with type 2 diabetes.
    He R; Hu Y; Zeng H; Zhao J; Zhao J; Chai Y; Lu F; Liu F; Jia W
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27155442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of neopterin as a biochemical marker for peripheral neuropathy in pediatric patients with type 1 diabetes: Relation to nerve conduction studies.
    Elbarbary NS; Ismail EAR; El-Hilaly RA; Ahmed FS
    Int Immunopharmacol; 2018 Jun; 59():68-75. PubMed ID: 29627577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy.
    Goel A; Shivaprasad C; Kolly A; Sarathi H A V; Atluri S
    PLoS One; 2017; 12(9):e0183973. PubMed ID: 28880907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.
    Hu YM; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ; Guo AS; Li JA; Su JB
    Endocrine; 2018 May; 60(2):292-300. PubMed ID: 29411305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association Between HbA1c Levels and Diabetic Peripheral Neuropathy: A Case-Control Study of Patients with Type 2 Diabetes Using Claims Data.
    Nozawa K; Ikeda M; Kikuchi S
    Drugs Real World Outcomes; 2022 Sep; 9(3):403-414. PubMed ID: 35725984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.